Clinical Research Division
Expertise of Comprehensive Clinical Research Teams
Our clinical research teams are the focal point for clinical trials that provide cutting edge treatment for patients at the University of Michigan Rogel Cancer Center. These teams of practicing clinicians work collaboratively with researchers across the cancer center to build a strong portfolio of clinical trials for our patients. We want to improve cancer care and create new and better treatments.
Clinical research teams are comprised of a range of experts in cancer research, including:
- Physicians from multiple disciplines (surgery, medicine, radiation oncology, pathology, neurology, radiology, gynecology)
- Translational cancer research scientists
- Advanced practice providers
- Clinical research coordinators
- Data managers
- Regulatory specialists
- Patient advocates
Clinical Research Teams Across Many Cancer Types
Across a wide range of cancer types, our teams review and prioritize proposed clinical trials arising from the University of Michigan Rogel Cancer Center members and national organizations both to ensure scientific merit and to increase the chances of successful implementation. Led by Associate Director Anne Schott, M.D., our clinical research enterprise includes the following specific clinical research teams:
- Biomedical Prevention and Genetics
- Bone Marrow Transplant
- Breast Oncology
- Childhood Cancer
- Connective Tissue Oncology
- Cutaneous Oncology
- Experimental Therapeutics
- Gastrointestinal Oncology
- Genitourinary Oncology
- Gynecologic Oncology
- Head and Neck Oncology and Endocrine Malignancies
- Hematologic Malignancies
- Neurologic Oncology
- Thoracic Oncology
Support for Clinical Research Studies across all Rogel Cancer Center Programs
Our clinical research teams collaborate with the University of Michigan Rogel Cancer Center scientific programs, helping to translate scientific discoveries into clinical trials. The clinical research teams provide perspective and support for the unique patient populations they represent. Although primarily focused on interventional cancer clinical trials, our clinical research portfolio also includes these types of studies:
Translational and Clinical Research Program
The Translational and Clinical Research (TACR) Program was created to foster clinical translation of research discoveries into clinical trials. The collaborative program establishes a needed scientific organizational framework to share information and ideas about pathways, biomarkers and treatment methods common to multiple diseases.
Collaboration with Population Sciences
In addition to TACR, clinical research teams frequently interact with the Cancer Epidemiology and Prevention and the Health Behaviors and Outcomes programs, part of the Rogel Cancer Center’s cancer control and population sciences division. The research in these programs focuses on preventing cancer, improving how cancer care is delivered and the improving the quality of life of patients with cancer.
Contact Us for More Information
If you would like more information about the clinical research teams or programs at the University of Michigan, please contact one of our team members.
Clinical Research Division
Associate Director: Anne Schott, M.D.
Translational & Clinical Research Program
Larry Baker, D.O.